Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Wei L, Song XR, Sun JJ, Wang XW, Xie L, Lv LY.

Cancer Biother Radiopharm. 2012 Dec;27(10):672-7. doi: 10.1089/cbr.2012.1241.

2.

[Effects of lysyl oxidase down-regulation on invasion, migration and E-cadherin protein expression of hypoxic lung cancer cells].

Wei L, Song XR, Sun JJ, Xie L, Wang XW, Lü LY.

Zhonghua Yi Xue Za Zhi. 2012 Nov 13;92(42):3004-7. doi: 10.3760/cma.j.issn.0376-2491.2012.42.015. Chinese.

PMID:
23328296
3.

Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.

Postovit LM, Abbott DE, Payne SL, Wheaton WW, Margaryan NV, Sullivan R, Jansen MK, Csiszar K, Hendrix MJ, Kirschmann DA.

J Cell Biochem. 2008 Apr 1;103(5):1369-78.

PMID:
17685448
4.

Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.

Ji F, Wang Y, Qiu L, Li S, Zhu J, Liang Z, Wan Y, Di W.

Int J Oncol. 2013 May;42(5):1578-88. doi: 10.3892/ijo.2013.1878.

5.

Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.

Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS.

Breast Cancer Res Treat. 2012 Aug;134(3):989-1004. doi: 10.1007/s10549-012-1986-8.

PMID:
22434522
6.

The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.

Baker AM, Cox TR, Bird D, Lang G, Murray GI, Sun XF, Southall SM, Wilson JR, Erler JT.

J Natl Cancer Inst. 2011 Mar 2;103(5):407-24. doi: 10.1093/jnci/djq569.

PMID:
21282564
7.

Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion.

Santhanam AN, Baker AR, Hegamyer G, Kirschmann DA, Colburn NH.

Oncogene. 2010 Jul 8;29(27):3921-32. doi: 10.1038/onc.2010.158.

8.

Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M, Hirakawa K.

Gastric Cancer. 2016 Apr;19(2):431-42. doi: 10.1007/s10120-015-0510-3.

PMID:
26100130
9.

Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.

Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA.

Cancer Res. 2005 Dec 15;65(24):11429-36.

10.

Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.

Laczko R, Szauter KM, Jansen MK, Hollosi P, Muranyi M, Molnar J, Fong KS, Hinek A, Csiszar K.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):631-43.

PMID:
17931358
11.

Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells.

Yang X, Li S, Li W, Chen J, Xiao X, Wang Y, Yan G, Chen L.

Oncol Rep. 2013 Feb;29(2):541-8. doi: 10.3892/or.2012.2146.

PMID:
23165370
12.

microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.

Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R.

J Cancer Res Clin Oncol. 2015 Mar;141(3):431-41. doi: 10.1007/s00432-014-1836-7.

PMID:
25245053
13.

[Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis].

Liu JL, Wei W, Tang W, Jiang Y, Yang HW, Li JT.

Zhonghua Yi Xue Za Zhi. 2012 May 29;92(20):1379-83. Chinese.

PMID:
22883193
14.

Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.

Xu CC, Wu LM, Sun W, Zhang N, Chen WS, Fu XN.

Mol Med Rep. 2011 Sep-Oct;4(5):1007-15. doi: 10.3892/mmr.2011.530.

PMID:
21725601
15.

The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.

Chen WL, Kuo KT, Chou TY, Chen CL, Wang CH, Wei YH, Wang LS.

BMC Cancer. 2012 Jun 29;12:273. doi: 10.1186/1471-2407-12-273.

16.

Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.

Yu Z, Sato S, Trackman PC, Kirsch KH, Sonenshein GE.

PLoS One. 2012;7(3):e33287. doi: 10.1371/journal.pone.0033287.

17.

Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival.

Wilgus ML, Borczuk AC, Stoopler M, Ginsburg M, Gorenstein L, Sonett JR, Powell CA.

Cancer. 2011 May 15;117(10):2186-91. doi: 10.1002/cncr.25768.

18.

Ionizing radiation induces tumor cell lysyl oxidase secretion.

Shen CJ, Sharma A, Vuong DV, Erler JT, Pruschy M, Broggini-Tenzer A.

BMC Cancer. 2014 Jul 22;14:532. doi: 10.1186/1471-2407-14-532.

19.

Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.

Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong SW, Li RL, Zhao MY, Zhen Y, Yu XL, Chen YY, Luo RC, Li R, Li LB, Deng XJ, Fang WY, Liu Z, Song X.

J Hematol Oncol. 2015 Mar 8;8:22. doi: 10.1186/s13045-015-0117-5.

20.

Silencing of lysyl oxidase gene expression by RNA interference suppresses metastasis of breast cancer.

Liu JL, Wei W, Tang W, Jiang Y, Yang HW, Li JT, Zhou X.

Asian Pac J Cancer Prev. 2012;13(7):3507-11.

Supplemental Content

Support Center